Role of Apathy in the Effectiveness of Weight Loss Interventions

NCT00548652 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 101

Last updated 2019-10-04

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to determine whether treating apathy with methylphenidate or medical Crisis counselling will increase adherence to weight loss programs thereby increasing their effectiveness

Conditions

Interventions

BEHAVIORAL

MOVE

is a VA based multidesciplinary weight loss intervention

BEHAVIORAL

medical crisis councelling

group counselling sessions

BEHAVIORAL

MOVE

is a VA based multidesciplinary weight loss intervention

DRUG

methyphenidate

methyphenidate will be used to treat apathy dose 10mg bid

BEHAVIORAL

MOVE

is a VA based multidesciplinary weight loss intervention

DRUG

methyphenidate

methyphenidate will be used to treat apathy dose 10mg bid

BEHAVIORAL

medical crisis councelling

group counselling sessions

BEHAVIORAL

MOVE

is a VA based multidesciplinary weight loss intervention

Sponsors & Collaborators

  • VA Nebraska Western Iowa Health Care System

    lead FED

Principal Investigators

  • Cyrus DeSouza, MD · VA Medical Center, Omaha

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
21 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-08-31
Primary Completion
2009-05-31
Completion
2009-05-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00548652 on ClinicalTrials.gov